SBIR/STTR Research Award

Developing Robust Subgroup Analysis Methods for Randomized Controlled Trials

Award identifier 56b9260a349a06633c1afe312b3d8dd7a44879941bf7266caf8e3884d80744cbAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$265,170

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MARTINGALE RESEARCH CORPORATION
Proposal award date
2019-07-01
Contract end date
2020-06-30
UEI
T9NGMH8MYAR3
Solicitation number
PA18-574
Topic code
NIDA

Research abstract

PROJECT ABSTRACTThe impact of substance abuseincluding tobaccoalcoholillicit drugsand prescription opioidsin the U Sis immensewith the combined cost of its effects on health carerelated crimeand lost productivity exceeding $billion each yearCritical to addressing this national crisis is the need for improved data analysis and statistical tools that enable substance abuse researchers to more effectively exploit their datasetsSuch tools provide improved detection and estimation of statistical regularitiesthus offering the opportunity for new clinical findings that support the accelerated development of targeted treatments for individuals or groups suffering from substance use disordersSUDIn particularimproving statistical methods and tools for subgroup analysis on clinical trial data would be invaluable to SUD researchSubgroup analyses are utilized in efficacy and effectiveness studies and randomized controlled trials to identify heterogeneity in treatment effectsHTEby assessing how clinical factors impact estimates of treatment effect sizesThis allows researchers to better understand and explain how patients respond differently when clinicalpatientand system factors moderate treatment effect sizesSuch analyses are also utilizedespecially in the absence of valid clinical theoryby practitionersadministratorsand policy makers to make decisions that impact patientstheir quality of lifeand health care costsThis study will extend and evaluate the Best Approximating ModelBAMtechnology as an advanced statistical modeling approach that offers improvements over conventional subgroup data analysis methodsFirstBAM uses a systematic model search and selection strategy to incorporate known or posited factors while simultaneously identifying subgroups and estimating their impact on treatment effect sizesSecondBAM includes robust estimationspecification analysisstochastic exhaustive model searchand validation within the single model selection framework of a generalized additive modelThirda BAM is designed to handle common problems encountered in subgroup analyses including possible model misspecification and overfitting as well as multicollinearitysmall sample size biasand Type I error inflation due to multiple comparisonsPhase I research will investigate extending BAM technology as an advanced statistical modeling tool andquot BAMHTEandquotfor robust subgroup analysis byiincorporating new model selection functionalityiiimplementing novel subgroup specification testing and validation methodsiiievaluating its reliability and validity for robust subgroup analysisandivdemonstrating its robust subgroup analysis capability on a NIDA fundedCTNdatasetPhase I results will establish the essential feasibility for Phase II BAM HTE prototype developmentevaluationand findings disseminationwhich in turn will provide the foundation for subsequent Phase III commercialization PROJECT NARRATIVEThe impact of substance abuseincluding tobaccoalcoholillicit drugsand prescription opioidsin the U Sis immensewith the combined cost of its effects on health carerelated crimeand lost productivity exceeding $billion each yearCritical to addressing this national crisis is the need for improved data analysis and statistical tools that enable substance abuse researchers to more effectively exploit their datasetsSuch tools provide improved detection and estimation of statistical regularitiesthus offering the opportunity for new research findings that support the accelerated development of targeted treatments for individuals or groups suffering from substance use disordersSUDIn particularimproving statistical methods and tools for subgroup analysis on clinical trial data would be invaluable to SUD researchThis Phase I feasibility study will investigate extending Best Approximating ModelBAMtechnology for subgroup analysis byiincorporating new model selection functionalityiiimplementing novel subgroup specification testing and validation methodsiiievaluating its reliability and validity for robust subgroup analysisandivdemonstrating its robust subgroup analysis capability on a NIDA fundedCTNdataset

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

32 SBIR/STTR records share this UEI (1987–2019). Reported award amounts total $10,833,491. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.